Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Apr 10.
doi: 10.1007/s00246-025-03834-4. Online ahead of print.

Stenting the Ductus Arteriosus in Neonates with Ductal-Dependent Pulmonary Blood Flow: Technical and Anatomic Considerations

Affiliations
Review

Stenting the Ductus Arteriosus in Neonates with Ductal-Dependent Pulmonary Blood Flow: Technical and Anatomic Considerations

Tacy E Downing et al. Pediatr Cardiol. .

Abstract

Patent ductus arteriosus (PDA) stenting is rapidly emerging as an initial palliative option for infants with cyanotic congenital heart disease and ductal-dependent pulmonary blood flow. Although less invasive than surgical systemic to pulmonary shunt placement, the procedure is technically challenging with a notable learning curve. The highly variable anatomy of the PDA contributes to procedural complexity, success rates, and adverse outcomes. This technical review proposes a scheme of best practices for PDA stenting based on the authors' experience and existing literature. We review pre-, intra-, and post-catheterization care, with an in-depth discussion of procedural strategy, equipment selection, and technical pitfalls relevant to each morphologic PDA sub-type.

Keywords: Catheterization; Ductal artery stent; Ductus arteriosus; Pulmonary atresia; Stent angioplasty; Tetralogy of Fallot.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of interest: The authors declare no competing interests. Disclosures: Dr Goldstein has reported consulting relationships with Medtronic, W.L. Gore & Associates, and Edwards Lifesciences; and is an advisory board member for PECA Labs and Mezzion Pharma. Dr Qureshi has reported consulting relationships with W.L. Gore & Associates, Edwards Lifesciences, and Abiomed. Dr Zampi has reported consulting relationships with Medtronic and W.L. Gore & Associates. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

References

    1. Bentham JR, Zava NK, Harrison WJ et al (2018) Duct stenting versus modified Blalock-Taussig shunt in neonates with duct-dependent pulmonary blood flow: associations with clinical outcomes in a Multicenter National Study. Circulation 137:581–588 - DOI - PubMed
    1. Glatz AC, Petit CJ, Goldstein BH et al (2018) Comparison Between patent ductus arteriosus stent and modified Blalock-Taussig shunt as palliation for infants with ductal-dependent pulmonary blood flow: insights from the congenital catheterization research collaborative. Circulation 137:589–601 - DOI - PubMed
    1. Ratnayaka K, Nageotte SJ, Moore JW et al (2021) Patent ductus arteriosus stenting for all ductal-dependent cyanotic infants: waning use of blalock-taussig shunts. Circ Cardiovasc Interv 14:e009520 - DOI - PubMed
    1. Bahaidarah S, Al-Ata J, Alkhushi N et al (2021) Outcome of ductus arteriosus stenting including vertical tubular and convoluted tortuous ducts with emphasis on technical considerations. Egypt Heart J 73:83 - DOI - PubMed - PMC
    1. Qureshi AM, Goldstein BH, Glatz AC et al (2019) Classification scheme for ductal morphology in cyanotic patients with ductal dependent pulmonary blood flow and association with outcomes of patent ductus arteriosus stenting. Catheter Cardiovasc Interv 93:933–943 - DOI - PubMed

LinkOut - more resources